trending Market Intelligence /marketintelligence/en/news-insights/trending/ea1BcEK0Lo5DgfX3GxhYwA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Bellerophon Therapeutics principal financial officer to resign

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Bellerophon Therapeutics principal financial officer to resign

Megan Schoeps intends to resign as Bellerophon Therapeutics Inc.'s controller and principal financial officer to pursue other career interests.

Schoeps is expected to continue in her current role until about January 2018 while the company completes an ongoing search for a replacement. She is also expected to provide transition assistance, as needed.